Follow
William Faubion
William Faubion
Professor Medicine, Mayo Clinic
Verified email at mayo.edu
Title
Cited by
Cited by
Year
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study
WA Faubion Jr, EV Loftus Jr, WS Harmsen, AR Zinsmeister, WJ Sandborn
Gastroenterology 121 (2), 255-260, 2001
15042001
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
WA Faubion, ME Guicciardi, H Miyoshi, SF Bronk, PJ Roberts, ...
The Journal of clinical investigation 103 (1), 137-145, 1999
6661999
Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease
W Afif, EV Loftus Jr, WA Faubion, SV Kane, DH Bruining, KA Hanson, ...
Official journal of the American College of Gastroenterology| ACG 105 (5 …, 2010
6042010
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
MA Kleinschek, K Boniface, S Sadekova, J Grein, EE Murphy, SP Turner, ...
Journal of Experimental Medicine 206 (3), 525-534, 2009
5622009
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial
CA Solem, EV Loftus Jr, JG Fletcher, TH Baron, CJ Gostout, BT Petersen, ...
Gastrointestinal endoscopy 68 (2), 255-266, 2008
4302008
Treatment of eosinophilic esophagitis with inhaled corticosteroids
WA Faubion Jr, J Perrault, LJ Burgart, NN Zein, ML Clawson, DK Freese
Journal of pediatric gastroenterology and nutrition 27 (1), 90-93, 1998
4081998
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
A Salas, C Hernandez-Rocha, M Duijvestein, W Faubion, D McGovern, ...
Nature reviews Gastroenterology & hepatology 17 (6), 323-337, 2020
3922020
Development of chronic colitis is dependent on the cytokine MIF
YP De Jong, AC Abadia-Molina, AR Satoskar, K Clarke, ST Rietdijk, ...
Nature immunology 2 (11), 1061-1066, 2001
3792001
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children
JS Hyams, A Griffiths, J Markowitz, RN Baldassano, WA Faubion Jr, ...
Gastroenterology 143 (2), 365-374. e2, 2012
3262012
Death receptors in liver biology and pathobiology
WA Faubion, GJ Gores
Hepatology 29 (1), 1-4, 1999
2911999
Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression
H Ji, G Liao, WA Faubion, AC Abadía-Molina, C Cozzo, FS Laroux, ...
The Journal of Immunology 172 (10), 5823-5827, 2004
2862004
The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study
S Khanna, LM Baddour, WC Huskins, PP Kammer, WA Faubion, ...
Clinical infectious diseases 56 (10), 1401-1406, 2013
2582013
The cell surface receptor SLAM controls T cell and macrophage functions
N Wang, A Satoskar, W Faubion, D Howie, S Okamoto, S Feske, C Gullo, ...
The Journal of experimental medicine 199 (9), 1255-1264, 2004
2412004
biological activity markers in inflammatory bowel disease
D Desai, WA Faubion, WJ Sandborn
Alimentary pharmacology & therapeutics 25 (3), 247-255, 2007
2372007
Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease
JS Hyams, MC Dubinsky, RN Baldassano, RB Colletti, S Cucchiara, ...
Gastroenterology 152 (8), 1901-1914. e3, 2017
2132017
SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages
SB Berger, X Romero, C Ma, G Wang, WA Faubion, G Liao, E Compeer, ...
Nature immunology 11 (10), 920-927, 2010
2012010
Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease
AB Dietz, EJ Dozois, JG Fletcher, GW Butler, D Radel, AL Lightner, ...
Gastroenterology 153 (1), 59-62. e2, 2017
1942017
Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures
S Samuel, DH Bruining, EV Loftus Jr, KT Thia, KW Schroeder, ...
Clinical Gastroenterology and Hepatology 11 (1), 49-54. e1, 2013
1822013
Challenges in pediatric inflammatory bowel disease
A Bousvaros, F Sylvester, S Kugathasan, E Szigethy, C Fiocchi, R Colletti, ...
Inflammatory bowel diseases 12 (9), 885-913, 2006
1762006
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
W Afif, JA Leighton, SB Hanauer, EV Loftus Jr, WA Faubion, DS Pardi, ...
Inflammatory bowel diseases 15 (9), 1302-1307, 2009
1632009
The system can't perform the operation now. Try again later.
Articles 1–20